Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Enepret Inc
Profile last edited on: 10/24/2019      CAGE: 7T4R7      UEI: P3KJFJJR58R4

Business Identifier: Synthetic biology
Year Founded
2017
First Award
2018
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

137 Edgemoor Drive
Lexington, KY 40503
   (859) 536-4593
   N/A
   www.enepret.com
Location: Single
Congr. District: 06
County: Fayette

Public Profile

Anchored in work undertaken by the principals at the University of Kentucky School of Pharmacy, Enepret is developing a novel process for fabrication of high quality oils with applications in the pharmaceuticals and cosmetics industries.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$224,703
Phase II Dollars
$2,996,311
Total Awarded
$3,221,014

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 2 NIH $3,221,014
Project Title: Evaluating Synthetic Biology Produced Triterpene Oils in Adjuvant Formulations

Key People / Management

  Joe Chappell -- Founder

  Chase Kempinski -- Chief Science Officer

Company News

 From Earthbound to Outer Space: Sending Plants to Orbit in the Name of Biomedicine